Dna chips and the pharmaceutical industry

Dna chips and the pharmaceutical industry

DNA CHIPS AND THE PHARMACEUTICAL INDUSTRY

INTRODUCTION

When future historians look back on the greatest scientific advancements of the 20th century, they will without a doubt focus on only three events: the Apollo Moon landing, the invention of the microprocessor, and possibly the greatest scientific endeavor yet, genomics, the science of identifying genes and how they work in humans. It is possibly not a total coincidence then that two of this centuries greatest advancements have grown out of the same cradle of technology, Silicon Valley. The first advancement was the invention of the microprocessor, and the second was the invention of the DNA chip, also called the DNA array or biochip.
These DNA chips are the newest tools being used in the study of genomics. DNA chips are changing the way researchers analyze the genetic make-up of cells, and will soon render traditional pharmaceutical research obsolete. This allows for whole new generations of drugs that will be made to combat diseases by effecting changes in a their specific genetic design.

PROBLEM STATEMENT

Currently the pharmaceutical industry is a very high risk industry in which fewer than one in ten promising drug products ever makes it through the testing phase and onto the shelves at the local pharmacy. The effect is that the production of a new drug is almost like a guessing game that may or may not produce any profit. A Company may have a long list of chemicals that could make possible drugs to treat a specific affliction, but by the time they narrow the list down, and do the necessary research and testing, they may have already spent possibly millions of dollars. In the end they may not even be left with a viable drug to market.

BACKGROUND

This section is designed to educate the reader on some of the background information needed to understand the nature of DNA chips, as well as to appreciate the benefits the chips could bring to pharmaceutical research. This section consists of the following sections: The Definition of DNA Chips, and The Pharmaceutical Industry Today.

The Definition of DNA Chips

DNA chips bear an amazing resemblance to microchips. DNA chips are basically pieces of silicon that are layered with a dense checkerboard-like grid of sites called features [2]. There are typically anywhere from 100,000 to 500,000 of these features on any given 2X2cm DNA chip. Attached at each feature are millions of copies of a single segment of DNA, which acts as a DNA probe. Each segment of DNA can range from a few nucleotides, to millions. Nucleotides are the chemical building blocks of DNA. There are only four nucleotides that make up every single strand of DNA in every living creature: adenine, guanine, cytosine, and thymine.
Any genetic material being tested is first labeled with a fluorescent marker. When the marked DNA is applied to the DNA chip, any strands of...

To view the complete essay, you be registered.